Salvage focal ablative therapy for radio-recurrent prostate cancer is safe and provides good short to medium-term oncological control
June 3, 2020
SonaCare Medical announces new study results that shows focal ablative salvage therapy after radio-recurrent prostate cancer is safe and provides good cancer control over 6 years.
Associated Urological Specialists Partners with Vituro Health to Offer HIFU Treatment for Prostate Cancer
February 20, 2020
HIFU technology will soon be available for prostate cancer patients in the Chicago area through the AUS’s partnership with Vituro Health.
Summerlin Hospital Medical Center First Hospital in Nevada to Add HIFU Technology with Vituro Health
October 10, 2019
Vituro Health and Summerlin Hospital Medical Center in Las Vegas, Nevada, are teaming up to provide High-Intensity Focused Ultrasound (HIFU) technology for prostate cancer patients. Summerlin is the first hospital in the state of Nevada to provide this revolutionary treatment for those with prostate cancer.